(Press-News.org) Montréal, April 20, 2014 - A new study by immunology researchers at the IRCM led by Javier M. Di Noia, PhD, sheds light on a mechanism affecting AID, a crucial enzyme for the immune response. The scientific breakthrough, published in the latest issue of The Journal of Experimental Medicine, could eventually improve the way we treat the common flu, as well as lymphoma and leukemia.
The researchers study white blood cells, called B-lymphocytes, whose main function is to produce antibodies to fight against infections. More specifically, they focus on an enzyme found in B cells known as AID, or activation-induced deaminase.
"AID is crucial for an efficient antibody response," explains Dr. Di Noia, Director of the Mechanisms of Genetic Diversity research unit at the IRCM. "However, high levels of AID can also have harmful effects and lead to certain cancer-causing mutations. The objective is to find the perfect level of AID activity to maximise the protection it provides to the body while reducing the risk of damage it can cause to cells."
The research team previously found that Hsp90, one of the most abundant and vital proteins found in cells, maintains the levels of AID by stabilizing it while it is still immature. In fact, they realized that inhibiting Hsp90 significantly reduces the levels of AID in the cell.
"Through this new study, we identified another mechanism, controlled by the protein eEF1a, that has the opposite effect," says Stephen P. Methot, PhD student in Dr. Di Noia's laboratory and first author of the article. "The protein eEF1a retains AID in the cell's cytoplasm, away from the genome. However, unlike Hsp90, it maintains AID in a ready-to-act state. We discovered that blocking the interaction between AID and eEF1a helps AID access the cell nucleus and thereby boosts AID activity. As a result, this could increase immune response and help fight infections, for instance."
"We found the eEF1a mechanism is necessary to restrict AID activity in the cell," adds Mr. Methot. "It acts as a buffer by allowing the cell to accumulate enough AID to be efficient, but limits its activity to prevent the oncogenic or toxic effects that could result if too much AID is in continuous contact with the genome."
The IRCM scientists identified two existing drugs that can act on the eEF1a mechanism to release AID into the cell. They could potentially be used to boost AID activity and, thus, immune responses.
"With this discovery, we now understand mechanisms that can both reduce and increase the activity of AID by targeting different proteins," concludes Dr. Di Noia. "This knowledge could eventually lead to new treatments to boost the immune system and help our aging population fight influenza, for example, as AID activity in our cells decreases with age. On the other hand, therapies could also be developed to lower toxic levels of AID in certain cancers such as B-cell lymphoma and leukemia."
INFORMATION:
About the study
The research project conducted at the IRCM was funded by the Canadian Institutes of Health Research, as well as through fellowships from the Cole Foundation and the Fonds de recherche du Québec - Santé. For this study, Dr. Di Noia's team also included PhD student Ludivine Litzler and research associate Astrid Zahn. The project was conducted in collaboration with Felipe Trajtenberg and Alejandro Buschiazzo from the Institut Pasteur de Montevideo in Uruguay, Francis Robert and Jerry Pelletier from McGill University, and Brad G. Magor from the University of Alberta. For more information, please refer to the article summary published online by The Journal of Experimental Medicine: http://jem.rupress.org/content/212/4/581?etoc.
About Javier M. Di Noia
Javier Marcelo Di Noia obtained a PhD in biochemistry from the University of Buenos Aires in Argentina. He is Associate IRCM Research Professor and Director of the Mechanisms of Genetic Diversity research unit. Dr. Di Noia is also associate research professor in the Department of Medicine (accreditation in biochemistry and molecular medicine, as well as microbiology, infectioloy and immunology) at the Université de Montréal, and adjunct professor in the Department of Medicine (Division of Experimental Medicine) at McGill University. He is a Canada Research Chairholder in Genetic Diversity. For more information, visit http://www.ircm.qc.ca/dinoia.
About the IRCM
The IRCM is a renowned biomedical research institute located in the heart of Montréal's university district. Founded in 1967, it is currently comprised of 35 research units and four specialized research clinics (cholesterol, cystic fibrosis, diabetes and obesity, hypertension). The IRCM is affiliated with the Université de Montréal, and the IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). It also maintains a long-standing association with McGill University. The IRCM is funded by the Quebec ministry of Economy, Innovation and Export Trade (Ministère de l'Économie, de l'Innovation et des Exportations).
WASHINGTON (April 20, 2015) - The use of continuous positive airway pressure was associated with a significant reduction in the recurrence of atrial fibrillation in patients with obstructive sleep apnea, according to an analysis of data from past research published today in the Journal of the American College of Cardiology: Clinical Electrophysiology.
Researchers from the New York University Langone Medical Center in New York City performed a meta-analysis of seven studies including 1,087 patients to determine if continuous positive airway pressure (CPAP) reduced the ...
Confronted by extreme scarcity of nutrients in an Australian dune ecosystem, the leaves of different plant species converge on a single efficient strategy to conserve phosphorus, an essential nutrient. But it is a different story underground, say researchers, including Ben Turner, staff scientist at the Smithsonian Tropical Research Institute. Plants on older dunes draw from a full bag of tricks, and take advantage of nearly all of the known adaptations for acquiring nutrients to capture the phosphorus they need.
"Plants cope with phosphorus scarcity in a similar way above-ground ...
Two new papers from the lab of Zach Schafer, Coleman Assistant Professor of Cancer Biology at the University of Notre Dame, offer insights into how breast cancer cells avoid anoikis, which is cell death induced by detachment from the extracellular matrix (ECM).
"Metastasis, the spread of cancer cells from the primary tumor site to distant sites in the body, is responsible for in excess of 90 percent of cancer deaths," Schafer said. "In order for cancer cells to metastasize, they must survive the trip from the primary tumor to a secondary site. A significant barrier to ...
In results presented at the American Association for Cancer Research (AACR) Annual Meeting 2015, a University of Colorado Cancer Center study shows that orally administering the chemical silibinin, purified from milk thistle, slows the ability of colorectal cancer stem cells to grow the disease. When stem cells from tumors grown in silibinin-fed conditions were re-injected into new models, the cells failed to develop equally aggressive tumors even in the absence of silibinin.
"It's very simple: tumors from mice that were initially fed silibinin had fewer cancer stem cells, ...
Researchers from The University of Manchester working with drug development company Evgen Pharma, have developed a new combination of drugs which could overcome treatment resistance and relapse in breast cancer.
In research to be revealed at the American Association of Cancer Research annual conference on Monday, the researchers show that in the most common type of breast cancer, affecting 70% of patients, the drug Sulforadex helps overcome resistance to routinely used hormonal treatments by targeting the cancer stem cell population.
While most women initially respond ...
HANOVER, N.H. - Dartmouth astrophysicists and their colleagues have not only proven that a supermassive black hole exists in a place where it isn't supposed to be, but in doing so have opened a new door to what things were like in the early universe.
Henize 2-10 is a small irregular galaxy that is not too far away in astronomical terms -- 30 million light-years. "This is a dwarf starburst galaxy -- a small galaxy with regions of very rapid star formation -- about 10 percent of the size of our own Milky Way," says co-author Ryan Hickox, an assistant professor in Dartmouth's ...
A new review of the ideas and work of Patrick Matthew, a little-known antecedent of Charles Darwin, argues that Matthew is under-appreciated even though he described the idea of large-scale evolution by natural selection decades before Darwin did. Some of his ideas were different from Darwin's but are equally valid.
"Patrick Matthew was a fascinating character--strong-willed and fiercely independent," said Dr. Michael Weale, author of the Biological Journal of the Linnean Society article. "Darwin used detailed, methodical force of argument to convince the world of evolution ...
For many students or junior academics--and even for senior investigators--initiating a new piece of research can be a daunting experience, and they often do not know where or how to begin. A recent Accounting and Finance article offers a simple new research tool that can act as a template designed for pitching research ideas to mentors or other experts.
The two-page pitching template includes 4 preliminary components: working title, research question, key papers, and motivation. Next is a '3-2-1 countdown' that is based on 3 elements - idea, data, and tools; 2 questions ...
Among soft-bodied cephalopods, vampire squid live life at a slower pace. At ocean depths from 500 to 3,000 meters, they don't swim so much as float, and they get by with little oxygen while consuming a low-calorie diet of zooplankton and detritus. Now, researchers reporting in the Cell Press journal Current Biology on April 20 have found that vampire squid differ from all other living coleoid cephalopods in their reproductive strategy as well.
While other squid reproduce all at once late in their lives, vampire squid appear to alternate between reproductive and resting ...
Household pets can transmit infection to people, especially those with weak immune systems, young children, pregnant women and seniors, according to an article in CMAJ (Canadian Medical Association Journal). Health care providers and pet owners should be aware of this risk to prevent illness in vulnerable people.
Surveys suggest that the general public and people at high risk for pet-associated disease are not aware of the risks associated with high-risk pet practices or recommendations to reduce them; for example, 77% of households that obtained a new pet following a ...
